Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001420506-25-002101·Bleichroeder LP
Schedule 13G ownership disclosure
NEUROONE MED TECHNOLOGIES CO
Common Shares · CUSIP: 64130M209
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bleichroeder LP
Shares: 4,000,000 · Class: 8.03%
- Bleichroeder Holdings LLC
Shares: 4,000,000 · Class: 8.03%
- Andew Gundlach
Shares: 4,000,000 · Class: 8.03%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001420506-25-002101
- Form type
- SCHEDULE 13G
- Filer
- Bleichroeder LP
- CIK
- CIK 1781002
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership